SEC Form 4 · accession 0001209191-15-007320
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Lee Ellis
Officer — EVP & Chief Financial Officer
Period of report
Jan 26, 2015
Accepted (ET)
Jan 28, 2015 · 9:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 26, 2015 | A | 171,237 | — | A | 171,237 | D | |
| Ordinary SharesF1 | Jan 26, 2015 | A | 5,093 | — | A | 5,093 | I | 401(k) |
| Ordinary SharesF1 | Jan 26, 2015 | A | 7,632 | — | A | 7,632 | I | ESOP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock option (right to buy)F2 | $56.74 | Jan 26, 2015 | A | 37,011 | A | — | Oct 19, 2015 | Ordinary Shares | 37,011 | 37,011 | D |
| Employee Stock option (right to buy)F3 | $48.70 | Jan 26, 2015 | A | 41,068 | A | — | Oct 30, 2016 | Ordinary Shares | 41,068 | 41,068 | D |
| Employee Stock option (right to buy)F4 | $47.77 | Jan 26, 2015 | A | 41,868 | A | — | Oct 29, 2017 | Ordinary Shares | 41,868 | 41,868 | D |
| Employee Stock option (right to buy)F5 | $36.24 | Jan 26, 2015 | A | 55,188 | A | — | Oct 27, 2018 | Ordinary Shares | 55,188 | 55,188 | D |
| Employee Stock option (right to buy)F6 | $35.92 | Jan 26, 2015 | A | 50,112 | A | — | Aug 3, 2019 | Ordinary Shares | 50,112 | 50,112 | D |
| Employee Stock option (right to buy)F7 | $37.53 | Jan 26, 2015 | A | 70,984 | A | — | Aug 2, 2020 | Ordinary Shares | 70,984 | 70,984 | D |
| Employee Stock option (right to buy)F8 | $34.88 | Jan 26, 2015 | A | 91,744 | A | — | Aug 1, 2021 | Ordinary Shares | 91,744 | 91,744 | D |
| Employee Stock option (right to buy)F9 | $38.81 | Jan 26, 2015 | A | 82,453 | A | — | Jul 30, 2022 | Ordinary Shares | 82,453 | 82,453 | D |
| Employee Stock option (right to buy)F10 | $41.60 | Jan 26, 2015 | A | 2,404 | A | — | Oct 29, 2022 | Ordinary Shares | 2,404 | 2,404 | D |
| Employee Stock option (right to buy)F11 | $55.32 | Jan 26, 2015 | A | 60,250 | A | — | Jul 29, 2023 | Ordinary Shares | 60,250 | 60,250 | D |
| Employee Stock option (right to buy)F12 | $55.32 | Jan 26, 2015 | A | 1,808 | A | — | Jul 29, 2023 | Ordinary Shares | 1,808 | 1,808 | D |
| Employee Stock option (right to buy)F13 | $62.76 | Jan 26, 2015 | A | 71,192 | A | — | Jul 28, 2024 | Ordinary Shares | 71,192 | 71,192 | D |
| Employee Stock option (right to buy)F14 | $62.76 | Jan 26, 2015 | A | 1,594 | A | — | Jul 28, 2024 | Ordinary Shares | 1,594 | 1,594 | D |
Explanation of responses
- F1Represents shares of Medtronic plc ("New Medtronic") acquired pursuant to the merger (the "Merger") of a wholly-owned subsidiary of New Medtronic with and into Medtronic, Inc. ("Medtronic"), with Medtronic surviving as a wholly-owned subsidiary of New Medtronic, in exchange for ordinary shares of New Medtronic, which was consummated after and conditioned on New Medtronic's acquisition of Covidien plc, by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. At the effective time of the Merger, each Medtronic common share was cancelled and converted into the right to receive one New Medtronic ordinary share. Under the terms of the Merger, the officer received cash in lieu of fractional shares of New Medtronic and restricted stock units were rounded up to the nearest whole share.
- F10This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F11This option to purchase 60,250 New Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 60,250 Medtronic common stock shares for $55.32 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F12This option to purchase 1,808 New Medtronic ordinary shares for $55.32per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,808 Medtronic common stock shares for $55.32per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F13This option to purchase 71,192 New Medtronic ordinary shares for $62.76 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 71,192 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F14This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F2This option to purchase 37,011 ordinary shares of New Medtronic for $56.74 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 37,011 Medtronic common stock shares for $56.74 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F3This option to purchase 41,068 New Medtronic ordinary shares for $48.70 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 41,068 Medtronic common stock shares for $48.70 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F4This option to purchase 41,868 New Medtronic ordinary shares for $47.77 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 41,868 Medtronic common stock shares for $47.77 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F5This option to purchase 55,188 New Medtronic ordinary shares for $36.24 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 55,188 Medtronic common stock shares for $36.24 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F6This option to purchase 50,112 New Medtronic ordinary shares for $35.92 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 50,112 Medtronic common stock shares for $35.92 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F7This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F8This option to purchase 91,744 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 91,744 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
- F9This option to purchase 82,453 New Medtronic ordinary shares for $38.81per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 82,453 Medtronic common stock shares for $38.81per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.